openPR Logo
Press release

Intra-amniotic Infection Treatment Market Leading Manufacturers Expected to Motivate Growth during 2018-2026 // Max cure drugs and pharmaceutical Ltd, Zydus cadila healthcare Ltd., Cipla Limited, Aristopharma Ltd

05-22-2019 09:45 AM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

Intra-amniotic Infection Treatment Market Leading

The global intra-amniotic infection treatment market is primarily driven by the increasing prevalence and recurrence of intra-amniotic infection across the globe. The disorder is common in women with lower gestational ages, which is the major factor expected to drive the growth of the Intra-amniotic Infection Treatment Market. The CDC and American Pediatrics Association have provided guidelines for assessing risk of neonatal infection. The guidelines recommend to conduct laboratory studies and empiric antibiotic therapy, which has led the pharmaceutical companies to launch new range of products for the treatment.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2184

Overall, the antibiotic-based treatment therapy will remain the first line of treatment for intra-amniotic infection, contributing majorly to the growth of the global intra-amniotic infection treatment market. Rapid increase in diagnostic procedures such as proteomic profiling and identification of novel biomarkers is further expected to surge the demand for intra-amniotic infection treatment over the forecast period. 

Intra-amniotic infection is a common occurrence in pregnant women, which affects both the mother and baby. Intra-amniotic infection is also known as chorioamnionitis. The incidence is high at lower gestational ages. The main mechanism for intra-amniotic infection is projected to be the ascending bacterial infection from the maternal genital tract. Intra-amniotic infection is the inflammatory process that mainly affects the chorioamniotic membrane, umbilical cord and the fetus. The intra-amniotic infection is associated with symptoms such as fever, uterine tenderness, and foul smelling amniotic fluid. If the treatment is not given at proper time the patient may develop severe complications of intra-amniotic infection such as still birth, cerebral palsy, preterm premature rupture of membrane. The standard treatment recommended for intra-amniotic infection includes antibiotic therapies. The antibiotics are given in various combinations depending upon the duration of pregnancy such as intrapartum and postpartum. Alternative therapies such as prophylaxis and diet modification may provide symptomatic relief and prevent recurrence, but are recommended along with standard antibiotics. Ampicillin and gentamicin are commonly recommended antibiotics for intra-amniotic infection. The polymicrobial intra-amniotic infection is confirmed by pathological tests such as gram staining, glucose level and histological evidence of placental infection. 

To know more about the Intra-amniotic Infection Treatment Market Visit the link- https://www.factmr.com/report/2184/intra-amniotic-infection-treatment-market

Intra-amniotic Infection Treatment Market: Overview

Several antibiotics are used for the treatment of intra-amniotic infection, but Metronidazole (Flagyl) by Pfizer is the most commonly used antibiotic, as it crosses the placental barrier and enters the fetal circulation rapidly, which is expected to fuel the growth of the therapeutics segment. Changes is lifestyle and eating habits are attributed to growing prevalence of intra-amniotic infection. In the upcoming years, the global intra-amniotic infection treatment market is expected to witness entry of new market players, which would increase the competition.

Intra-amniotic Infection Treatment Market: Regional Outlook

On the basis of geography, the global intra-amniotic infection treatment market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is expected to hold large revenue share in the global intra-amniotic infection market primarily due to increasing prevalence of intra-amniotic infection, growing investment in the healthcare sector and increasing awareness among the general population regarding intra-amniotic infection treatments. In addition, improved living conditions and health care initiatives by governing bodies are factors expected to fuel the growth of the intra-amniotic infection treatment market in Latin America. Western Europe followed by Asia Pacific is expected to be the second fast-growing regional market for intra-amniotic infection treatment. 

Intra-amniotic Infection Treatment Market: Key Players

Examples of some of the key players operating in the global intra-amniotic infection treatment market are Pfizer limited, Max cure drugs and pharmaceutical Ltd, Zydus cadila healthcare Ltd., Cipla Limited, and Aristopharma Ltd., among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2184

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - http://westminsternewsonline.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intra-amniotic Infection Treatment Market Leading Manufacturers Expected to Motivate Growth during 2018-2026 // Max cure drugs and pharmaceutical Ltd, Zydus cadila healthcare Ltd., Cipla Limited, Aristopharma Ltd here

News-ID: 1748686 • Views: 212

More Releases from Fact.MR

Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel
07-02-2020 | Health & Medicine
Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
06-02-2020 | Health & Medicine
Fact.MR
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online

All 5 Releases


More Releases for Infection

Shigella Infection (Shigellosis) Therapeutics- Pipeline Analysis 2018
Shigella infection, also known as shigellosis, is a bacterial infection caused by a family of bacteria known as shigella. The main symptom of this infection is diarrhea, and can be passed through direct contact with the bacteria in the stool. Download the sample report @ https://www.pharmaproff.com/request-sample/1072 The other sign and symptoms associated with shigella infection are abdominal pain, cramps, and fever. Children between the age of two and four years are
Infection Prevention and Control
Infection control products and accessories aids in the prevention and control of hospital associated & other healthcare infections. These products range from disinfectants to sterilization equipment used in the healthcare settings. Infections needs to be controlled while injecting the drugs, during the surgery and hospital stay of a patient. In addition, infection control and preventive measures aid to avoid the most common hospital infections among the healthcare staff. Get Free 10
Infection Surveillance Solutions Market Drivers With Outlook
North America is expected to hold a dominant position in global infection surveillance solutions market due to high adoption of infection surveillance solutions by hospitals in the U.S. and Canada. For instance, in 2014, Tucson Medical Center (TMC), a U.S.-based hospital installed infection surveillance solution from RL Solutions and in 2014, Trillium Health Partners, a Canada-based hospital has installed RL Solutions’ automated infection surveillance throughout its organization. Click To Continue
Influenza B Infection Market Endeavors Growth 2025
Global Influenza B Infection Market: Snapshot Influenza B infection is considered as one of the common conditions that affects a large number of people across the globe, caused due to the influenza virus B genera of the family. The condition of influenza B infection requires proper medications and treatments in order to avoid severe complications. At present, several medicines and vaccinations are made available in order to reduce the incidence of
Gram-Negative Bacterial Infection Market - Infection-type Segmentation 2017 - 20 …
Global Gram-Negative Bacterial Infection Market: Snapshot Worldwide, antimicrobial resistance is a soaring concern for a range of diseases, especially for enteric fever, respiratory tract infections, and various infections related with gram-negative bacilli (GNB). An upsurge in antibiotic resistance is mainly due to indiscriminate and inappropriate use of antibiotics and a marked decline in the development of efficacious antimicrobial agents. According to the Centers for Disease Control and Prevention (CDC), the
Infection Surveillance Solutions Market
Infection surveillance solution helps healthcare facilities in reporting patient-associated data to the state and federal authorities. Integration of infection surveillance software with already existing networks of medical facilities and hospitals is an easy process. A recent report published by Persistence Market Research (PMR) estimates the global infection surveillance solution market to register a staggering 14.04% CAGR during the forecast- 2017 to 2025. The US$ 316.67 Mn market is likely to